Skip to search formSkip to main contentSkip to account menu

carboxyphthalato-1,2-diaminocyclohexaneplatinum

Known as: 1,2-diaminocyclohexane(4-carboxyphthalato)platinum(II), (4-carboxyphthalato)(1,2-diaminocyclohexane)-platinum(II), DACCP 
A second-generation platinum analog with potential antineoplastic activity. Dacplatinum alkylates DNA at the N-7 position of guanine, thereby… 
National Institutes of Health

Related topics

Related topics

2 relations

Narrower (1)

JM-82

Broader (1)

Organoplatinum Compounds

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
1985
Review
1985
[Current status of clinical results of new antitumor drugs].
This review describes the current clinical results of phase I and II trials of new antitumor drugs such as the new anthracyclines… 
1984
1984
Pharmacological and preclinical toxicological studies of 1,2-diaminocyclohexane(isocitrato)platinum(II).
The antitumor activity of a new highly water-soluble platinum derivative, (1,2-diaminocyclohexane)(isocitrato)platinum(II) (NSC… 
1984
1984
Phase-II trial of 1,2-diaminocyclohexane (4-carboxyphthalato) platinum (II) (DACCP) in non-small cell lung cancer
SummaryA phase-II trial of the second-generation platinum analog 1,2-diaminocyclohexane (4-carboxyphalato) platinum (II) (DACCP… 
1984
1984
Phase II trial of 1,2‐diaminocyclohexane‐(4‐carboxyphth‐alato) platinum(II) (DACCP) in colorectal carcinoma
IN AN EFFORT TO INVESTIGATE THE ANTITUMOR ACTIVITY of new cisplatin analogues, 1,2-diaminocyclohex-ane-(4-carboxyphthalato… 
Review
1983
Review
1983
[Development of antitumor platinum complexes].
Since the discovery of the antitumor activity of cis-dichlorodiammine platinum (II) in various tumor systems by B. Rosenberg in… 
Review
1983
Review
1983
[Current clinical status of new anticancer drugs].
4'-Epiadriamycin demonstrated considerable efficacies in lymphomas, breast cancer and soft part sarcomas with reduced… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)